Spots Global Cancer Trial Database for Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
Official Title: An Observational Study：Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
Study ID: NCT04683770
Conditions
Interventions
Study Description
Brief Summary: Our study is aimed to explore a prospective observational clinical study on the efficacy prediction and survival prediction of HR + / HER2 - biomarkers detection in patients with advanced breast cancer. This study is a prospective, observational clinical study. We analyzed the incidence of biomarker mutations in HR + / HER2 - advanced breast cancer (stage IV), and the correlation between biomarkers and therapeutic efficacy, survival, and prognosis.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Sun Yat Sen Memorial Hospital，Sun Yat sen University, Guangzhou, Guangdong, China
Contact Details
Name: Jianli Dr. Zhao, doctor
Affiliation: Study Principal Investigator
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
